Search

everythinglearnresearchcommunity

for

Search:↓

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

Hair loss in women often doesn't follow a pattern, isn't linked to age, may be genetic, and can be related to thyroid issues or other health factors.

Accurate clinical, histological, and genetic methods are key for understanding and treating hair disorders.

Hormones, nutrition, and seasonal changes regulate hair growth cycles, with androgens extending growth phases and factors like aging and malnutrition affecting hair loss and thinning.

The hair follicle infundibulum plays a key role in skin health and disease, and understanding it better could lead to new skin disease treatments.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Tinea capitis is a common scalp infection causing hair loss, mostly in young children.

Using anabolic-androgenic steroids can cause skin problems like acne and hair loss in athletes.

Minoxidil doesn't affect perifollicular lymphoid infiltration in alopecia areata patients.

Finasteride and dutasteride effectively stop or reverse hair loss in women with androgenetic alopecia, with dutasteride being more effective for women under 50.

Anthralin is effective for psoriasis and alopecia with minimal systemic side effects but can irritate the skin.

IL-1 alpha stops hair follicle growth and hair production.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Researchers created early-stage hair-like structures from skin cells, showing how these cells can self-organize, but more is needed for complete hair growth.

Scalp hair grows at 0.37 mm/day, forearm hair at 0.18 mm/day, and thigh hair at 0.30 mm/day, with no significant differences found in people with certain hair conditions.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

Hair loss is a rare but recognized symptom of pemphigus vulgaris, with patients usually regrowing hair after treatment.

ATP increases melanin production in skin after UV exposure, with the P2X7 receptor being crucial for this process.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

Graying hair happens due to aging and might be delayed by new treatments.

Black patients with discoid lupus erythematosus have more severe skin damage and higher chances of dyspigmentation, scalp, and ear involvement.

Red clover extract improved hair, skin, mood, sleep, and tiredness in postmenopausal women.

Researchers found a new mutation causing total hair loss from birth.

Local skin glucocorticoid production is crucial for healthy skin, and its disruption can lead to skin diseases.

WNT activation in scalp fibroblasts boosts hair growth by increasing FGF9.